FIBROBLAST GROWTH FACTOR 21 POTENTLY REDUCES ATHEROSCLEROSIS AND NASH DEVELOPMENT

被引：0

作者：

Liu, C. ^{[1
,2
]}

Schonke, M. ^{[1
,2
]}

Spoorenberg, B. ^{[1
,2
]}

Lambooij, J. ^{[3
,4
]}

Hendrik, V. D. Z. ^{[3
]}

Zhou, E. ^{[1
,2
]}

Dekker, N. ^{[5
]}

Andreasson, A-C ^{[6
]}

Park, A. ^{[7
]}

Uhrbom, M. ^{[6
]}

Ahlstedt, I. ^{[6
]}

Ikeda, Y. ^{[7
]}

Wallenius, K. ^{[6
]}

Peng, X-R ^{[6
]}

Guigas, B. ^{[3
]}

Boon, M. ^{[1
,2
]}

Wang, Y. ^{[1
,2
]}

Rensen, P. ^{[1
,2
]}

机构：

[1] Leiden Univ, Dept Med, Med Ctr, Leiden, Netherlands

[2] Leiden Univ, Einthoven Lab Expt Vasc Med, Med Ctr, Leiden, Netherlands

[3] Leiden Univ, Dept Parasitol, Med Ctr, Leiden, Netherlands

[4] Leiden Univ, Dept Cell & Chem Biol, Med Ctr, Leiden, Netherlands

[5] AstraZeneca BioPharmaceut R&D, Discovery Sci, Gothenburg, Sweden

[6] AstraZeneca, BioPharmaceut R&D, Biosci Metab Res & Early Dev Cardiovascr Renal &, Gothenburg, Sweden

[7] AstraZeneca, Oncol R&D, Biol Engn & Targeted Delivery, Gaithersburg, MD USA

来源：

ATHEROSCLEROSIS | 2022年 / 355卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

SE123

引用

页码：E74 / E75

页数：2

共 50 条

[1] The role of fibroblast growth factor 21 in atherosclerosis
Kokkinos, John
Tang, Shudi
Rye, Kerry-Anne
Ong, Kwok Leung
ATHEROSCLEROSIS, 2017, 257 : 259 - 265
[2] Fibroblast Growth Factor 21 Mimetics for Treating Atherosclerosis
Kwok, Kelvin H. M.
Lam, Karen S. L.
ENDOCRINOLOGY AND METABOLISM, 2017, 32 (02) : 145 - 151
[3] FIBROBLAST GROWTH FACTOR 21: A POWERFUL THERAPEUTIC FOR HYPERCHOLESTEROLEMIA AND ATHEROSCLEROSIS
Liu, C.
Schonke, M.
Zhou, E.
Li, Z.
Kooijman, S.
Larsson, M.
Wallenius, K.
Peng, X. -R.
Wang, Y.
Rensen, P.
ATHEROSCLEROSIS, 2020, 315 : E16 - E17
[4] Fibroblast growth factor therapy in NASH
Van Epps, Heather
LANCET GASTROENTEROLOGY & HEPATOLOGY, 2017, 2 (07): : 472 - 472
[5] Effects of fibroblast growth factor 21 on cell damage in vitro and atherosclerosis in vivo
Zhu, Wenhe
Wang, Changwen
Liu, Lei
Li, Yan
Li, Xiaokun
Cai, Jianhui
Wang, Huiyan
CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, 2014, 92 (11) : 927 - 935
[6] Sex Modifies the Association of Fibroblast Growth Factor 21 With Subclinical Carotid Atherosclerosis
Chee, Yingjie
Toh, Grace Lx
Lim, Chien Joo
Goh, Liuh Ling
Dalan, Rinkoo
FRONTIERS IN CARDIOVASCULAR MEDICINE, 2021, 8
[7] Fibroblast growth factor 21
Trusz, Guillaume J.
DIFFERENTIATION, 2024, 139
[8] GENDER DIFFERENCES IN THE ASSOCIATION BETWEEN FIBROBLAST GROWTH FACTOR 21 AND SUBCLINICAL CAROTID ATHEROSCLEROSIS
Chee, Y. J.
Lim, C. J.
Goh, L. L.
Toh, L. X. G.
Dalan, R.
ATHEROSCLEROSIS, 2020, 315 : E128 - E128
[9] Role of fibroblast growth factor 15 in the development of high fat diet induced NASH
Schumacher, Justin D.
Kong, Bo
Pan, Yang
Zhan, Le
Sun, Runbin
Aa, Jiye
Richardson, Jason R.
Laskin, Debra
Guo, Grace L.
HEPATOLOGY, 2015, 62 : 669A - 669A
[10] Relationship of fibroblast growth factor 21 with subclinical atherosclerosis and cardiovascular events: Multi-Ethnic Study of Atherosclerosis
Ong, Kwok Leung
Campbell, Steven
Wu, Ben J.
McClelland, Robyn L.
Kokkinos, John
Szklo, Moyses
Polak, Joseph F.
Allison, Matthew A.
Rye, Kerry-Anne
ATHEROSCLEROSIS, 2019, 287 : 46 - 53

← 1 2 3 4 5 →